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This  literature  review  pursues  two  main  objectives:  ﬁrst,  it argues  that  research  on  health
policy actors  and  healthcare  systems  need  to  be separated  more  thoroughly.  Though  there
are  important  interactions  between  both  ﬁelds,  it is  often  advisable  to  separate  analytically
research  on health  policy  actors  and  on  healthcare  systems.  Second,  concentrating  not  only
on  actors  and  institutions  but  also  on  outcomes,  we  suggest,  is theoretically  valuable,  practi-eywords:
omparative methods
eview
ealth policy
olitics
ealthcare systems
cally  feasible,  and  policy  relevant.  Most  studies  discussed  in this  review  concentrate  either
on  health  policy  implementation  or  on  healthcare  system  characteristics.  Our emphasis
is on extending  the  understanding  about  the  outcomes  of  different  national  healthcare
arrangements  and  whether  policy  reforms  actually  deliver  their  promised  results.  To  do
this,  more  attention  to the  measurement  of success  is  required.
 utcomes
. Introduction
Formal healthcare, the work that patients, doctors,
urses, druggists, and hospitals do when facing real or
eared illness, is everywhere a topic of concern. The pol-
tics of that world – where by politics we mean the role
f governmental policy in the ﬁnancing, delivering, and
egulating that care – is among the nations of the OECD
f great salience. National (and often international) media
eport healthcare developments regularly, with attention
sually riveted on the costs and quality of the care deliv-
red or denied. In recent decades, the performance of
ountries other than one’s own has gained considerable
rominence. Where once policy elites and scholars learned
f “foreign” medical care arrangements from books and
eports by knowledgeable authors, the range of commenta-
ors now is much wider and arguably less knowledgeable.
he sources of cross-national commentary include televi-
ion interviews across borders, quick trips by party leaders
o discover what “best practices” can be found abroad,
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and thin portraits of national arrangements that interna-
tional organizations deliver from time to time. The various
disciplines – from the social scientists to the biomedical
specialists reporting about the medical care practices they
know from collegial exchanges – produce bewilderingly
diverse portraits of how healthcare works in this or that
country.
This essay is about this complicated portraiture,
addressing the topic through the lens of comparative,
cross-national analysis. Its mode is a literature review.
Its approach is two-fold: how to understand the liter-
ature addressing the politics and policy processes that
shape, sustain or reform the medical care arrangements
of any society. What does this literature tell us about the
political processes – the interplay of governmental insti-
tutions, interest groups, and political ideas – that shape
the operations of the medical care world? Such an inquiry
is applied political sociology and this literature can, we
believe, be approached with the following simple model
in mind (Fig. 1).
The second topic is the descriptive and explana-
Open access under CC BY-NC-ND license.tory scholarship about what is conventionally termed
“healthcare systems.” How is healthcare ﬁnanced, pro-
vided, and regulated, and what are the outcomes of
different national care arrangements? Fig. 2 sets out the
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Fig. 1. Ideas, interests, and institution
typical categories of writing in these areas (see [1] for an
overview).
From this perspective, our review addresses the follow-
ing question: does the analysis concentrate on healthcare
politics or on healthcare systems? There are useful studies
that combine the analysis of decision-making in healthcare
with that of institutional structures [2–4]. This research
approach has undoubtedly illuminated the role of political
actors in different healthcare arenas. However, we  suggest
that sharply separating both parts can be analytically help-
ful. Both the healthcare system and its speciﬁc institutional
architecture are the results of policy decision-making. Even
if studies combine the analysis of health politics and health-
care systems, it is analytically meaningful to reveal the
main focus of research.
Comparative studies of health politics and policy can
also be classiﬁed by whether or not they address substan-
tive outcomes. Healthcare arrangements can be read as
the programmatic results of policy decision-making. How
health reforms are implemented is a crucial component to
the analysis. When comparing healthcare systems, on the
other hand, we want to know how they function, what they
produce [5].  That means we should attend to the outcomes
of healthcare systems for patients, the insured, and citi-
zens. Without performance information, there is no strong
evidence with which to design healthcare reform [6].
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Fig. 2. Actors, institutions, healthcalthcare source: adapted from [1: xxv].
Deﬁning health policy goals, such as improving cost
effectiveness, augmenting population health, and assuring
patient safety as well as performance monitoring [6,7], are
examples how health policy decision making can be better
informed.
We do not address a number of health policy stud-
ies. Country reports such as the European Observatory
on Health Systems and Policies series provide detailed
and increasingly up-to-date country descriptions (health
system proﬁles, or HiTs) and are invaluable sources for
comparative analysis. Volumes that collect country reports
together with an editorial introduction and summary con-
clusion, labeled by Marmor et al. [8] as “stapled national
case studies,” can also provide important information for
cross-border learning (see, for example, the excellent vol-
umes by Altenstetter and Bjorkmann [9] and Okma and
Crivelli [10]). Other books address a particular theme in
health policy: for example, healthcare ﬁnancing [11], pri-
mary care [12], and decentralization in healthcare [13].
We have not included such studies in this article because
we  want to concentrate on comparative studies addressing
overall healthcare systems. The comparative focus on over-
all healthcare systems has some disadvantages, of course.
Comparing complex arrangements of various countries
necessarily requires a broad focus while implementing
health policy reform requires knowledge about speciﬁc
fosisylanA
tors &  
ns 
Healthca re syst ems 
tical  
 actor s 
olicy 
c) Regulati on, 
financing an d 
organization of 
Healthcare s yste ms  
y actors 
 re sults 
d) Healt hcare syste ms  
& outco mes (such as 
access, qualit y, equity,  
satisfaction) 
re systems, and outcomes.
ealth Po
p
t
m
t
t
p
p
I
t
u
a
t
m
i
u
i
s
t
c
i
(
c
2
h
e
s
o
p
r
t
o
c
k
f
o
s
s
t
p
f
c
i
p
i
s
d
2
h
E
s
a
gT. Marmor, C. Wendt / H
rograms. However, efﬁciency gains in one or another fea-
ure of healthcare or particular type of hospital does not
ean, as US experience demonstrates, higher efﬁciency for
he overall healthcare system [1].  Accordingly, research on
he latter topic remains highly relevant.
The following questions focus our review: What pur-
ose is the comparative work – whether its focus is
olitics or medical care arrangements – meant to serve?
s it simply to give the reader a different perspective
hrough comparison, without policy implications? Is it to
nderstand why policies, or programs, worked reason-
bly well in some settings and not others? Is the focus on
reating other similar national settings as natural experi-
ents for predicting what will happen in the context of
nterest? Finally, what concepts and methods have been
sed when comparing broadly healthcare politics and pol-
cy? These questions motivated our review, one form of
tocktaking.
The following sections review the literature according
o the four categories mentioned above (see Fig. 2): (a) the
entral political institutions and actors in healthcare pol-
cy; (b) health policy actors and health policy outcomes;
c) healthcare systems; and (d) healthcare systems and out-
omes.
. Conceptual frameworks for comparing
ealthcare politics and policy
The contemporary literature has placed increasing
mphasis on comparative methods. Earlier comparative
tudies typically concentrated on a very limited number
f countries. The aim was to understand in detail the com-
lexities of the healthcare arrangements in question. More
ecent comparative work has used conceptual frameworks
hat permit studying a much larger number of countries,
ften combining both macro and micro levels of analysis.
Drawing policy lessons from the experience of other
ountries requires, it is commonly and rightly claimed,
nowledge about contextual factors [14]. An analytical
ramework that captures the relevant institutional factors
f the political environment on the basis of a standardized
et of indicators is one way to satisfy this criterion. At the
ame time, however, these studies often do not include
he results of health policy implementation. Many com-
arisons of healthcare systems have a similar bias – or
eature. They focus on the institutional structure and do not
oncentrate on outcomes such as health status or health
nequalities. If we want to learn more about improved
ractice in healthcare systems, however, studies need to
nclude outcome measures. And if we want to learn about
uccessful health policy implementation, we need both to
eﬁne and measure health policy results.
.1. The role of political institutions and actors in
ealthcare policy
This has been a particularly rich ﬁeld of scholarship.
llen Immergut is one of the seminal scholars. Her 1992
tudy [15] of Swiss, Swedish, and French health policy
nalyzed what shaped the power of the major interest
roups in healthcare policymaking. She demonstrated thatlicy 107 (2012) 11– 20 13
veto opportunities – ones arising from speciﬁc features of
national political institutions – crucially inﬂuenced what
policies were adopted. Physicians’ organizations, for exam-
ple, had less inﬂuence on the health policy process than
generally believed. Immergut’s hypothesis, that veto points
in the political system are more important than veto groups
within society, has prompted other scholarship. For exam-
ple, Döhler and Manow [16] have illustrated how the
inﬂuence of medical provider groups is further weakened
when ﬁnancial resources are sharply reduced. According to
this literature, retrenchment reduces the power of physi-
cian groups, but the degree to which that takes place varies
with the institutional context.
The institutionalist perspective was carried to some-
thing of an extreme by Steinmo and Watts in their 1995
article [17], “It’s the Institutions, Stupid! Why  Comprehen-
sive National Health Insurance Always Fails in America.”
That article concentrated on an American institutional set-
ting in which legislative stalemate is common, and on a
reform episode in 1993–1994 that was over-determined.
The importance of historical legacies for health policy
development is part of this line of scholarly argument.
Hacker’s 1998 study [18] of the historical sequence and
timing of health policy change in Britain, Canada, and the
United States is illustrative. Hacker identiﬁed three con-
ditions that arguably inﬂuenced the health policy path
of these countries. The achievement of universal health
insurance, he stipulates, is less likely when (1) a sizable
part of the population has physician-dominated private
health insurance before national health insurance is on
the political agenda; (2) public insurance reform targets
residual populations from the outset; and (3) medical care
was a substantial industry before the idea of universal
health insurance became politically salient. Hacker wants
to explain the enduring American conﬂicts over universal
health insurance as the result of the United States’ satisfy-
ing all three conditions. Using path-dependency, Wilsford
[19] explored the timing and scope of healthcare reform
in Germany, France, Great Britain, and the United States.
Large-scale policy change is highly unusual, he rightly
argues. But some institutional structures are more con-
ducive to big-bang reforms than others. Wilsford correctly
asserts that both the British and German structures are
institutionally more open to large-scale reform than is the
US political structure.
A second stream in the literature concentrates on
what issues and with what resources the state addresses
healthcare [2–4]. Tuohy [3,20] provided one of the most
theoretical approaches for analyzing models of governance
in the healthcare arena. Concentrating on the question of
accountability in healthcare, Tuohy [20] argued that the
dominant model has shifted from an agency to a con-
tract one. In the trust-based principal-agent relationship,
the state (the principal) delegates authority for regulat-
ing and distributing healthcare to the medical profession
(the agent). According to Tuohy [20], this system, which
placed the physician at the center of the decision-making
process of healthcare provision, dominated medical
care – at least in Canada, the US, and UK – until the
end of the 20th century. New information technology,
Tuohy contends, has provided governments with much
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better information, reducing the information asymmetry
between state actors and physicians. This strengthened
another governance model, the contract model, in which
the state both ﬁnances and purchases healthcare. Accord-
ing to Tuohy, the medical profession, from the late 1980s
on, lost some of its earlier power not so much because of
increased cost pressures as because of the state’s superior
access to relevant medical information.
Typologies represent a third cluster of writing in
the ﬁeld of health politics. Such work is more expan-
sive in geographic scope, with more than three or four
countries studied. Like Tuohy, Moran [21] analyzed mod-
els of governing healthcare. Instead of focusing on the
state-doctor relationship, however, he classiﬁed healthcare
politics according to three central concepts: “consump-
tion,” “provision,” and “production.” The “consumption”
dimension describes the basis of eligibility for patients
to access healthcare and the funding mechanisms that
allocate ﬁnancial resources to healthcare. The “provision”
dimension describes who controls and regulates hospi-
tals and doctors. And the “production” (or technology)
dimension encompasses mechanisms that regulate med-
ical innovation (see also [22]). Using these dimensions as
analytic tools, Moran identiﬁed four ideal types of health-
care politics: (1) the “entrenched command-and-control
state,” represented by the Scandinavian countries and
Great Britain; (2) the “supply state,” illustrated by the US;
(3) the “corporatist state,” represented by Germany; and (4)
the “insecure command-and-control state,” exempliﬁed
by Greece and Portugal. The typology is meant to illumi-
nate which actors dominate these four types of healthcare
states. In “supply states,” provider interests dominate in all
three dimensions, while in “command-and-control states,”
the government is central in all three areas. In “corpo-
ratist healthcare states,” public-law bodies and doctors’
associations are the most powerful. “Insecure command-
and-control states” are problematic. Formally, the state
is dominant. In fact, such states “lack the administrative
capacities for guaranteeing universal coverage and equal
access to healthcare services, principles that have charac-
terized the healthcare systems of the Nordic countries and
Great Britain for many decades” [1: xix].
Another typology was advanced by Wendt et al. in
2009 [23]. They distinguished healthcare arrangements
by the role state-, non-governmental (societal)-, and pri-
vate actors have in the ﬁnancing, provision, and regulation
of healthcare. The result is a classiﬁcatory scheme of 27
types of healthcare politics, three of which are ideal types.
In “state healthcare systems,” ﬁnancing, service provi-
sion, and regulation are carried out by political actors.
In “societal healthcare systems,” by deﬁnition societal
actors dominate all three dimensions. And in “private
healthcare systems,” private for-proﬁt actors dominate all
three dimensions. For each ideal-type, there are six mixed
combinations in which state-, societal-, or private actors
dominate two dimensions. Six further combinations do not
approach any of the three ideal-types. This methodolog-
ical framework allows one to identify more ﬁne-graded
differences in healthcare politics as well as changes
over time. Germany, for instance, is not identiﬁed as an
ideal-typical corporatist healthcare state, as suggested bylicy 107 (2012) 11– 20
Moran. Rather, it is a mixed, more complicated type in
which corporate actors control the ﬁnancing and regulation
while provision is dominated by private actors. Central and
Eastern European countries (CEE) provide another illustra-
tion of complexity. Formally speaking, they replaced their
former socialist arrangements with social health insurance
schemes. But according to Wendt et al.’s methodologi-
cal framework, these countries are correctly classiﬁed as
state-based systems because social insurance and corpo-
rate actors are, in fact, weak and healthcare services are
largely provided in public institutions.
This framework also suggests a classiﬁcatory basis for
understanding policy transformations. There is (1) “system
change,” such as a shift from a societal-based to a state-
based healthcare system, which is expected “to arise only in
exceptional instance in which drastic turns in policy goals
meet high public acceptance” [23: 83]; (2) an “internal sys-
tem change,” which occurs for instance if the provision of
healthcare services becomes dominated by private instead
of state actors while ﬁnancing and regulation remain in
state hands; and (3) an “internal change of levels,” in which
changes can be indentiﬁed on one or more dimensions
but without a transformation of the dominant mode of
healthcare ﬁnancing, provision, or regulation. Due to the
difﬁcult measurement of regulation, however, typologies
of health policy decision making have so far not been used
for empirically analyzing country differences and changes
in healthcare politics.
2.2. Health policy actors and institutions and health
policy outcomes
The comparative analyses of governance institutions
and constellations of political actors provide a better
understanding of the possible results of healthcare poli-
tics, but often do not measure them. The results of health
policy decision-making include cost-containment, prior-
ity setting and rationing, coverage, and solidarity – among
other possibilities [24]. A number of studies take up these
topics. Most either focus on single countries [e.g., 25,26]
or analyze outcomes without specifying the governance
structures and actor constellations that produced or shaped
the results [e.g., 11,27].  Looking forward, we would hope
that consistent criteria for measuring policy change and
health policy outcomes in a larger number of countries will
become more common. But, as Pierson suggests,
there is probably no substitute for investigations that
pay attention to fairly detailed dimensions of policy
change [. . .]. Rigorously applying consistent criteria to
even a small subset of afﬂuent democracies is a time-
consuming and expertise-taxing enterprise. Carrying
out such research for the afﬂuent democracies as a
whole would require the efforts of a large and well-
funded team. So far no one has carried it out [28: 421]
The European Observatory on Health Systems and Poli-
cies provides a platform for collecting relevant information
on a number of countries. In this context, Kutzin [29]
has suggested a methodological approach for comparing
health policy results. Lessons from the implementation of
healthcare ﬁnancing reforms, according to Kutzin, can ﬁrst
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e drawn by using a common set of explicit health policy
bjectives as criteria for assessing the reform processes.
he second suggestion is a “function-based framework”
or capturing the existing healthcare ﬁnancing system. The
hird suggestion involves identifying and analyzing the key
ontextual factors that have major implications for par-
icular reform options and the related outcomes. Using
his framework, Kutzin et al. [30] characterized the imple-
entation of health policy reforms in Central and Eastern
uropean transition countries over twenty years. Their
ain conclusion about the reform experience in transi-
ion countries is rather general: “Coherent and successfully
mplemented reform strategies require clear identiﬁcation
f speciﬁc policy objectives, based on analysis of critical
ealth system performance problems, and careful choice
f a combination of well-aligned policy instruments that
espond to the identiﬁed problems” [30: 384].
Wendt and Kohl [31] analyzed the impact of pub-
ic policies on the transformation of ﬁnancial resources
nto healthcare provision in 22 OECD countries. Coun-
ries with a higher share of public health expenditure,
hey suggest, are more successful in controlling healthcare
osts. Financial resources are not, however, linearly trans-
erred into healthcare provision. Countries with a strong
hare of private health insurance have high costs and low
evels of healthcare provision. Countries with strong cor-
orate actors (e.g., Austria, Belgium, France, and Germany)
hat invest above-average levels of ﬁnancial resources in
ealthcare also achieve above-average levels of health-
are provision. Strong states, on the other hand, such as
enmark and Great Britain, have healthcare expenditure
evels below the OECD average, but their levels of health-
are provision are also lower. Only a few countries, such as
inland and Luxembourg, achieve above-average health-
are provision with ﬁnancial resources below the OECD
ean. But Wendt and Kohl do not provide in-depth infor-
ation about the role of health policy actors in achieving
uch a favorable combination.
Few comparative studies have concentrated on health
olicy results other than health expenditures or levels of
ealthcare provision. But contemporary policy conﬂicts go
ar beyond this narrow focus. Universal access to med-
cal care, patients’ choice, and equity and solidarity are
ll issues on the health policy agenda [1,24].  Compar-
ng Belgium, Germany, and the Netherlands, Maarse and
aulus [32] argue that the political culture of European
elfare states remains powerful. Market principles, they
ontend, have not sharply reduced solidarity. Analyzing
he dimensions of “risk solidarity,” “income solidarity,” and
scope,” Maarse and Paulus found evidence that solidarity
as even increased and remains a key principle in Euro-
ean social health insurance. Addressing earlier British and
wedish health policy reform, Saltman [33] showed that
tate regulation increased to safeguard solidarity in health-
are systems in which market principles appeared to gain
mportance.
The comparative studies discussed so far have con-
ributed innovative methodological frameworks and some
ew understandings of the results of health policy reforms.
hey have not, however, contributed frameworks for
ssessing the role of health policy actors within the reformlicy 107 (2012) 11– 20 15
processes. Hassenteufel et al. [34], however, do offer an
actor-centered approach to health policy change. They
propose that “we. . . pay close attention to precisely who
defends a particular reform program and how idea formu-
lation links to speciﬁc policy decisions in a given case. Once
we know who  and how, we  must not forget to ask why” [34:
528]. They conclude that programmatic actors are decisive
in explaining particular health policy results. Speciﬁc actors
transform available health policy instruments into health
reform programs. That is why  it is so crucial to know who
presses for particular policies and how those are related to
institutional and economic contexts.
2.3. Healthcare systems
We now turn to comparing systems of healthcare pro-
vision and in particular to how they are organized and
ﬁnanced. This ﬁeld includes comparative studies with a
fundamental theoretical orientation that take into account
the healthcare’s high level of complexity. These are typ-
ically studies of similarities and differences in a limited
number of countries. A larger number of countries can be
included in the analysis when the comparison is based on
few, pre-selected criteria.
There are, of course, numerous studies of comparative
ﬁnancing and expenditure [e.g., 35–40] and of healthcare
provision [e.g., 4,41–42]. Very few comparative studies
cover the overall arrangements for funding, delivering,
and regulating healthcare. A good example of the latter
is Blank and Burau’s [43] textbook on comparative health
policy. It introduces scholars and students to the complex-
ity of health policy and medical care and describes how
healthcare is delivered, ﬁnanced, and regulated in different
countries. Another recent textbook is by Gauld [44], who
compares the healthcare programs of New Zealand, Great
Britain, and the United States. His analysis is guided by the
theoretical assumption that healthcare has moved from a
“neoliberal” to a “social-democratic” era in health policy.
Gauld argues that healthcare quality improvement is ﬁrmly
planted on the health policy agenda in New Zealand, Great
Britain, and the United States. There is, Gauld contends,
greater alertness to coordinated and patient-centered care
in the three national settings he studied, and he emphasizes
that healthcare information technology has changed the
relationship between policy makers, funders, healthcare
providers, and patients, all of whom have been empow-
ered via better access to information. Interestingly, the
tax-funded British NHS seems to be particularly innova-
tive with regard to information technology. Patients are
provided with better information and therefore power in
the care-giving process, most visibly in Great Britain and
New Zealand. Gauld [44] sees this as a social-democratic
response to preceding neoliberal arrangements. The US
healthcare system, on the other hand, is by comparison not
only an example of market failures [1] but also of a sys-
tem with relatively low levels of patient information and
involvement and public satisfaction [44].Typologies group healthcare systems by using a few
pre-selected criteria. The OECD study “Financing and Deliv-
ering Health Care,” prepared by Schieber in 1987 [45],
distinguished healthcare arrangements on the following
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three dimensions: (1) access to healthcare measured by the
degree of population coverage; (2) the sources of ﬁnanc-
ing, such as general taxation, social insurance, or private
insurance; and (3) the public-private mix  of healthcare
provision. For Schieber, there were three basic health-
care arrangements: (1) a national health service model
with universal coverage, tax funding, and public owner-
ship of healthcare provision (e.g., Sweden, Great Britain);
(2) a social insurance model with universal coverage,
social insurance ﬁnancing, and public or private owner-
ship of facilities for provision (e.g., Germany); and (3) a
private insurance model with private coverage, ﬁnanc-
ing, and ownership of provision (e.g., the United States)
[45]. The OECD concept combined modes of governance
and healthcare system characteristics such as the degree
of coverage. Later typologies concentrated even more on
different modes of governance and therefore on the role
of political actors in the healthcare arena [see above; in
particular, 3,21–24].
Only recently have typologies with a focus on patients
and in particular on patients’ access to healthcare emerged
[46,47]. According to Reibling [47:5], “putting access at the
centre of a health typology strengthens a patients’ perspec-
tive and thereby the impact of health services on individual
health.” The patient-oriented typologies aim to understand
better the relationships among healthcare systems, access
to healthcare services, and health outcomes. They do not,
however, directly measure the effects of healthcare sys-
tems on health status or other outcomes (see below).
Wendt [46] used the following eight criteria for clas-
sifying healthcare systems: total healthcare expenditure,
the public-private mix  of healthcare ﬁnancing, private
out-of-pocket payment, out-patient healthcare provision,
in-patient healthcare provision, entitlement to healthcare,
remuneration of medical doctors, and patients’ access to
healthcare providers. Based on these criteria, he identiﬁed
three types of healthcare organization: (1) a “health service
provision-oriented type” characterized by a high number of
healthcare providers and free access for patients to medical
doctors (Austria, Belgium, France, Germany, and Luxem-
bourg); (2) a “universal coverage – controlled access type”
in which healthcare is a right of citizenship and equal access
to healthcare is more important than freedom of choice
(Denmark, Great Britain, Sweden, Italy, and Ireland); and
(3) a “low budget – restricted access type” with limited
ﬁnancial resources for healthcare and in which patients’
access to healthcare is restricted by high co-payments
and the regulation that patients be on a general practi-
tioner’s (GPs) list for extended periods (Finland, Portugal,
and Spain).
Reibling [47] focused even more on patients’ access
to the supply of healthcare services, using the crite-
ria of gatekeeping, cost-sharing, provider density (GPs,
specialists, and nurses), and medical technology (mag-
netic resonance imaging units/MRI, computed tomography
scanners/CT). Classifying European healthcare systems by
these criteria yields the following four types: (1) “ﬁnan-
cial incentives states” that regulate patients’ access to
medical doctors mainly by cost-sharing (Austria, Belgium,
France, Sweden, and Switzerland); (2) “strong gatekeeping
and low supply states” with no cost-sharing but extensivelicy 107 (2012) 11– 20
gatekeeping arrangements for doctor’s visits and a low
numbers of healthcare providers and relatively little med-
ical technology (Denmark, the Netherlands, Poland, Spain,
and Great Britain); (3) “weakly regulated and high sup-
ply states” with weak gatekeeping and a high supply of
healthcare providers (the Czech Republic, Germany, and
Greece); and (4) “mixed regulation states” that combine
gatekeeping and cost-sharing arrangements (Finland, Italy,
and Portugal).
None of the comparative studies reviewed in this sec-
tion directly measures the outcomes of healthcare systems.
By outcomes, we mean the utilization of healthcare ser-
vices, people’s perception of healthcare systems, and their
health statuses.
2.4. Healthcare systems and outcomes
One inﬂuential study on health outcomes is that by
Nolte and McKee [48]. They describe healthcare systems
as complex institutions serving multiple functions. To
relate population health outcomes to healthcare, Nolte and
McKee used the concept of “amenable mortality.” By that
they mean “deaths from certain causes that should not
occur in the presence of timely and effective health care”
[48,59]. They found that “amenable mortality” accounted
for about 23% of total mortality in males and about 32% in
females in 2002/03, with huge country variation. Between
1998 and 2002/03, the “amenable mortality gap” among
countries widened since ischemic heart disease mortality
was  reduced by more than 20% in some countries (France,
Great Britain) while remaining almost at the same level
in the United States. Even if healthcare is not measured
directly, the concept of “amenable mortality” can be used to
draw conclusions about medical care areas where improve-
ments seem particularly needed [see also 5,49,50].
Mackenbach et al. [51] studied differences in health
results in 22 European countries to identify some imme-
diate determinants of country variations. They concluded
that differences in mortality are strongly related to
inequalities in access to healthcare. In this interpreta-
tion, differences in mortality that are related to the
socio-economic position may  well result from conditions
amenable to intervention by healthcare providers. This is
especially so in Eastern Europe. Since Scandinavian coun-
tries show no smaller inequalities in health than the rest of
Europe, they suggest “that although a reasonable level of
social security and public services may  be a necessary con-
dition for smaller inequalities in health, it is not sufﬁcient”
[52: 2479].
Neither Nolte and McKee nor Mackenbach et al. directly
measured healthcare. Studies on targets and performance
measurement could potentially step in but have so far,
with few exceptions, concentrated on single countries [52].
Comparative studies on health policy processes could even
combine the analysis of healthcare reform, health pol-
icy implementation, and healthcare system outcomes. As
dimensions for measuring healthcare system performance,
Smith et al. [7] suggest “health status,” “clinical quality and
appropriateness of care,” “responsiveness of the health-
care system,” “equity,” and “productivity.” In a comparative
study that is based on this work, Smith et al. [6] discuss
ealth Po
h
m
b
t
o
d
i
i
c
i
c
s
t
s
i
i
r
p
t
e
e
d
b
8
e
s
h
v
w
c
a
w
a
c
p
t
l
m
p
t
t
h
c
a
t
s
e
t
h
f
v
f
n
G
w
t
nT. Marmor, C. Wendt / H
ealth policy targets in various countries but they do not
easure outcomes.
Reviewing 45 studies published on health inequities
etween 1992 and 2008, Beckﬁeld and Krieger [53] contend
hat researchers on healthcare systems and researchers
n health outcomes have rarely communicated directly
espite common interests. Only nine out of forty-ﬁve stud-
es have concentrated on the effect of the healthcare system
tself on health inequities, and none of the nine studies was
omparative.
When including macro-indicators in comparative stud-
es on health and health disparities, authors have so far
oncentrated on welfare state typologies, not healthcare
ystems. Conley and Springer [54], for example, analyzed
he inﬂuence of healthcare expenditures and of welfare
tate regime types on infant mortality. They found that
ncreased investment in healthcare associates with a lower
nfant mortality rate. However, when analyzing welfare
egime types, only the “Corporatist” welfare state showed a
ositive effect, not the “Social-democratic” or the “Liberal”
ypes. Without directly analyzing the healthcare system
ffect, the authors concluded that there is “no convincing
vidence that the institutional structure of the health care
elivery system matters in determining the ‘bang for the
uck’ – that is, the impact of state health expenditure” [54:
01].
Focusing on health and health inequalities more gen-
rally, Eikemo et al. [55] asked to what extent welfare
tate typologies can explain the variation of self-perceived
ealth in Europe. Since social transfers and welfare ser-
ices reduce inequality, they assumed that a developed
elfare state should have some bearing on health out-
omes as well. Their key ﬁnding is that the Scandinavian
nd Anglo-Saxon welfare states seem to have advantages
ith respect to population health compared with Southern
nd East European welfare states, and that welfare state
haracteristics seem to represent important factors in self-
erceived health among European nations. But some 90% of
he variation in self-perceived health was at the individual
evel, and only about 10% was at the country level. Further-
ore, from a classic welfare regime perspective, the high
erformance of Anglo-Saxon countries in Europe is coun-
erintuitive. Eikemo and colleagues therefore assume that
he advantage of Anglo-Saxon countries on self-perceived
ealth is related to the national health services in these
ountries, not the welfare state more generally.
Measuring patients’ utilization of healthcare services is
nother way to analyze outcome variations among coun-
ries. The relation between utilization differences among
ocio-economic groups and healthcare features has been
xtensively investigated in the equity literature, especially
he work of van Doorslaer et al. [60,61].  Differences in
ealthcare utilization between income groups emerged
rom several cross-sectional analyses. One general obser-
ation is that poorer people use medical services more
requently. This relationship disappears when controls for
eed are introduced. Van Doorslaer et al. also found that
P visits are characterized by a (slight) pro-poor difference
hile specialist visits show a strong pro-rich differentia-
ion. Medical specialist visits are unequally distributed in
early all countries, irrespective of system characteristics.licy 107 (2012) 11– 20 17
In addition, the main share of specialist inequity is found
when analyzing whether people have seen a specialist at all
and not in the conditional number of specialist visits. Van
Doorslaer and Masseria [60] conclude that inequity here is
rather more patient-initiated than doctor-driven.
In a similar study, Reibling and Wendt [62] intro-
duced healthcare system indicators and asked whether the
formal regulation of patients’ access to the healthcare sys-
tem through a gatekeeping system inﬂuences differences
in healthcare utilization among income and educational
groups. They found that the degree of gatekeeping has a sig-
niﬁcant effect on healthcare utilization among educational
groups. Countries with almost no access regulation (e.g.,
Belgium, France, and Germany) show huge differences in
healthcare utilization between those with the highest level
of education and with the lowest education level. When
patients’ access to healthcare providers is strictly regu-
lated through a gatekeeping system (e.g., in Denmark, the
Netherlands, and Spain), there are very few differences in
the number of specialist visits among educational groups.
“Objective outcomes” need to be distinguished from
“subjective outcomes.” “Subjective outcomes” can be
measured and compared by portraying how healthcare
arrangements are understood by the population. Most
studies report high levels of public support for European
healthcare systems [56–58].  This also bolsters the hypoth-
esis that universal welfare state institutions covering the
middle classes are likely to receive strong public sup-
port [28]. According to Gelissen [57], the healthcare arena
enjoys a high level of solidarity, and public support seems
largely independent of social class or income level. When
analyzing the importance of macro-level indicators, Wendt
at al. [59] found that the level of public healthcare expendi-
ture and the amount of private out-of-pocket payment are
both positively related to public support of a strong role
of the state. Furthermore, the higher the level of public
healthcare expenditure is, the higher the level of satis-
faction with the overall healthcare system is. The level of
out-of-pocket payment is not related to satisfaction. There
is also no correlation between the level of satisfaction and
whether patients have a free choice of doctors or whether
formal access to doctors is regulated through gatekeeping.
The ﬁndings suggest that both a high number of service
providers in the out-patient sector and especially the avail-
ability of general practitioners are of great importance.
3. Conclusion
Our reading of the comparative literature on health
politics and healthcare systems documents considerable
theoretical and methodological research. We  already have
substantial evidence of health policy change, relevant
health policy actors, and the main institutional characteris-
tics of healthcare systems. At the same time, the reviewed
literature shows considerable heterogeneity. However, it
is not plausible to search for “the overarching method” in
comparative healthcare research. There is no “canon of the
scientiﬁc literature” in health policy – that is, a research
agenda for comparative studies that relies on a common
set of theoretical and empirical approaches [1].
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Our literature review took up two main objectives: ﬁrst,
we argued that research on health policy actors and health-
care systems needed to be separated more thoroughly.
Though there are important interactions between both
ﬁelds, it is often advisable to separate research on health
policy actors and on healthcare systems analytically. This
becomes obvious when our second objective comes into
play. Concentrating not only on actors and institutions but
also on outcomes may  combine the strengths of different
disciplines and is theoretically valuable, practically feasi-
ble, and policy relevant. Exploring feedback loops from
policy outcomes may  inform the study of policy processes.
Outcome research may  show, moreover, that the political
determinants of health inequities are alterable [5,53].  Fur-
thermore, healthcare systems themselves are the outcomes
of health policy decisions, which demonstrates the inter-
relationship between health policy actors and healthcare
systems.
For both areas of research, there is often a trade-off
between theoretical depth and the number of countries
included in the comparative analysis since a single author,
or few authors, can only assess very few of these highly
complex institutions in detail [8]. When comparing a larger
number of countries, it is necessary to pre-select a feasible
set of dimensions that are analyzed in precisely the same
way for all countries included.
Rothgang et al. [63], for instance, suggested using the
dimensions of “regulation,” “ﬁnancing,” and “provision” for
analyzing the changing role of the state in healthcare. In
addition to funding and organization, Gauld [44] used the
dimensions of “healthcare quality” and “information tech-
nology”. The selection of appropriate dimensions and the
interpretation of the results require a broad knowledge
of the healthcare systems investigated and a theoretical
framework justifying the selection of indicators and dimen-
sions.
The reviewed studies have indicated that the ideal-
typical method may  represent a useful tool for measuring
changes in the role of health policy actors and also for iden-
tifying most-similar and most-different cases for detailed
comparisons of healthcare politics and policy. Typologies
have the advantage that they allow for the inclusion of
a larger number of countries in the analysis. Typologies
may  also provide a basis for bridging the macro-micro link
in comparative studies in such instances as when analyz-
ing the outcomes of certain health policy constellations.
Typologies of health policy actors have concentrated on
governance concepts [3,30],  and Moran has applied the
governing concepts “consumption,” “provision,” and “pro-
duction” to contrasting four healthcare states. Wendt et al.
[23] classiﬁed healthcare politics by asking for the role of
governmental-, societal-, and private actors in healthcare
provision, ﬁnancing, and regulation. Both typologies pro-
vide methodological frameworks that, however, have so
far not been analyzed empirically, a shortcoming related
to the difﬁcult measurement of regulation.
Typologies of healthcare systems have gone one step
further and have classiﬁed healthcare systems on the basis
of empirical information. Reibling [47] has used the dimen-
sions of “gatekeeping,” “cost-sharing,” “provider density,”
and “medical technology,” and Wendt [46] has classiﬁedlicy 107 (2012) 11– 20
healthcare systems by using the dimensions of “healthcare
expenditure,” “public-private mix  of ﬁnancing,” “private
co-payments,” “level of healthcare provision,” “entitlement
to healthcare,” “remuneration of medical doctors,” and
“patients’ access to healthcare providers.” Both typologies
focus on the supply side as well as on the demand side of
healthcare provision. So far, however, healthcare system
typologies have mainly served descriptive purposes, and
outcomes related to healthcare system types remain to be
measured.
The challenge of drawing defensible policy lessons from
comparative scholarship remains daunting. The problem is
not only that ﬁndings come from different methodological
frameworks but that accurate characterization is a pre-
condition for sensible lesson-drawing. Klein [14: 1269],
emphasizes that “the challenge to improving our capac-
ity to learn from the experience of other countries is to
deepen our understanding of the respects in which they
differ or are similar.” The task of health policy learning has
important implications for future comparative research.
For instance, by including outcome-measures, we may
improve our understanding about what healthcare reforms
and the functioning of healthcare systems mean for indi-
vidual patients. A theory-guided set of dimensions has, we
contend, been helpful in analyzing the role of health pol-
icy actors, healthcare systems, and health policy outcomes.
We need to extend our understanding about the outcomes
of different national healthcare arrangements and whether
policy reforms actually deliver results. To do this, we  need
to pay more attention to the measurement of success.
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